131 related articles for article (PubMed ID: 37336836)
1. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
[TBL] [Abstract][Full Text] [Related]
2. UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.
Liu X; Ma F; Liu C; Zhu K; Li W; Xu Y; Li G; Niu Z; Liu J; Chen D; Li Z; Fu Y; Qian C
Cell Death Dis; 2020 Jan; 11(1):10. PubMed ID: 31907353
[TBL] [Abstract][Full Text] [Related]
3. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
[TBL] [Abstract][Full Text] [Related]
4. Plekhg4 is a novel Dbl family guanine nucleotide exchange factor protein for rho family GTPases.
Gupta M; Kamynina E; Morley S; Chung S; Muakkassa N; Wang H; Brathwaite S; Sharma G; Manor D
J Biol Chem; 2013 May; 288(20):14522-14530. PubMed ID: 23572525
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.
Chen S; Yang J; Zhang Y; Duan C; Liu Q; Huang Z; Xu Y; Zhou L; Xu G
J Biol Chem; 2018 Jul; 293(29):11296-11309. PubMed ID: 29871923
[TBL] [Abstract][Full Text] [Related]
6. Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.
Ullah K; Zubia E; Narayan M; Yang J; Xu G
FEBS J; 2019 Jun; 286(11):2018-2034. PubMed ID: 30468556
[TBL] [Abstract][Full Text] [Related]
7. Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promotes Thyroid Cancer Cell Proliferation and Migration via Ubiquitin-Dependent Degradation of Kisspeptin-1.
Yan C; Su H; Song X; Cao H; Kong L; Cui W
Cell Physiol Biochem; 2018; 49(5):2047-2059. PubMed ID: 30244247
[TBL] [Abstract][Full Text] [Related]
8. High Level of Ubiquitin Conjugate Enzyme E2O Indicates Poor Prognosis of Patients with Hepatocellular Carcinoma.
Lan SY; Ding Y; Wang C; Fang J; Ren C; Liu JL; Kang H; Chang Y
Curr Med Sci; 2023 Feb; 43(1):93-103. PubMed ID: 36269535
[TBL] [Abstract][Full Text] [Related]
9. Gα
Castillo-Kauil A; García-Jiménez I; Cervantes-Villagrana RD; Adame-García SR; Beltrán-Navarro YM; Gutkind JS; Reyes-Cruz G; Vázquez-Prado J
J Biol Chem; 2020 Dec; 295(50):16920-16928. PubMed ID: 33023908
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies binding to ubiquitin-fold modifier-conjugating enzyme 1 (Ufc1) and pleckstrin homology domain containing, family G (with RhoGef domain) member 2 (Plekhg2) are associated with mycobacterial infections.
Tellermann A; Witte T; Lansche C; Stoll M; Schmidt RE; Baerlecken NT
HIV Med; 2015 Feb; 16(2):114-21. PubMed ID: 25213431
[TBL] [Abstract][Full Text] [Related]
11. UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance.
Huang Y; Yang X; Lu Y; Zhao Y; Meng R; Zhang S; Dong X; Xu S; Wu G
Cell Death Differ; 2021 Feb; 28(2):671-684. PubMed ID: 32901121
[TBL] [Abstract][Full Text] [Related]
12. Over expression of ubiquitin-conjugating enzyme E2O in bone marrow mesenchymal stromal cells partially attenuates acute myeloid leukaemia progression.
Tian C; Chen Z; Wang L; Si J; Kang J; Li Y; Zheng Y; Gao Y; Nuermaimaiti R; You MJ; Zheng G
Br J Haematol; 2023 Feb; 200(4):476-488. PubMed ID: 36345807
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
Xu Y; Zhang Z; Li J; Tong J; Cao B; Taylor P; Tang X; Wu D; Moran MF; Zeng Y; Mao X
J Hematol Oncol; 2017 Jul; 10(1):132. PubMed ID: 28673317
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA HCG18 Promotes Malignant Phenotypes of Breast Cancer Cells
Liu X; Qiao K; Zhu K; Li X; Zhao C; Li J; Feng D; Fang Y; Wang P; Qian C; Qiao W
Front Cell Dev Biol; 2021; 9():675082. PubMed ID: 34976998
[TBL] [Abstract][Full Text] [Related]
15. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy.
Shen T; Cai LD; Liu YH; Li S; Gan WJ; Li XM; Wang JR; Guo PD; Zhou Q; Lu XX; Sun LN; Li JM
J Hematol Oncol; 2018 Jul; 11(1):95. PubMed ID: 30016968
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.
Guo F; Fu Q; Wang Y; Sui G
J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.
Wang ZL; Wang C; Liu W; Ai ZL
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693087
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
[TBL] [Abstract][Full Text] [Related]
19. lncRNA ZNF674-AS1 inhibits the migration, invasion and epithelial-mesenchymal transition of thyroid cancer cells by modulating the miR-181a/SOCS4 axis.
Le F; Li HM; Lv QL; Chen JJ; Lin QX; Ji YL; Yi B
Mol Cell Endocrinol; 2022 Mar; 544():111551. PubMed ID: 34990740
[TBL] [Abstract][Full Text] [Related]
20. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
